Inovio Pharmaceuticals Inc (NASDAQ: INO) stock closed at $10.18 on 3/8/24 after a major increase of 12.7%. Moreover, unusually high trading volume at 193% of normal accompanied the advance. The stock has risen 14.9% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
INO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Inovio Pharmaceuticals has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Inovio Pharmaceuticals has a poor Appreciation Score of 23 but a very high Power Rating of 91, leading to the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment